Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fractional Flow Reserve Guided Primary Multivessel Percutaneous Coronary Intervention to Improve Guideline Indexed Actual Standard of Care for Treatment of ST-elevation Myocardial Infarction in Patients With Multivessel Coronary Disease

NCT01399736 is registered in ClinicalTrials.gov with Maasstad Hospital as lead sponsor.

NCT NCT01399736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01399736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fractional Flow Reserve Guided Primary Multivessel Percutaneous Coronary Intervention to Improve Guideline Indexed Actual Standard of Care for Treatment of ST-elevation Myocardial Infarction in Patients With Multivessel Coronary Disease
Lead sponsor
Maasstad Hospital
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2011
Completion date
October 31, 2018
Enrollment
885 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

multivessel coronary artery disease, myocardial infarction